Abstract

515P A MRI-based radiomics model for predicting the response to anlotinb combined with temozolomide in recurrent malignant glioma patients

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Bevacizumab plus etoposide among recurrent malignant glioma patients: Phase II study final results
K B Peters ... J J Vredenburgh
Journal of Clinical Oncology | VOL. 27
K B Peters, et. al.K B Peters ... J J Vredenburgh
20 May 2009
Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients.
Andrea Salmaggi ... Antonio Silvani
Journal of neuro-oncology | VOL. 66
Andrea Salmaggi, et. al.Andrea Salmaggi ... Antonio Silvani
01 Jan 2004
Angiogenic and procoagulant factors in plasma of brain tumor patients treated with bevacizumab.
Laura Conti ... Andrea Pace
Journal of Clinical Oncology | VOL. 32
Laura Conti, et. al.Laura Conti ... Andrea Pace
20 May 2014
P17.64 * ANGIOGENIC AND PROCOAGULANT FACTORS IN PLASMA OF BRAIN TUMOUR PATIENTS TREATED WITH BEVACIZUMAB
A Antenucci ... L Conti
Neuro-Oncology | VOL. 16
A Antenucci, et. al.A Antenucci ... L Conti
01 Sep 2014
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: ‘ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe’, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Re: Parker CC, Petersen PM, Cook AD, et al. Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial [NCT00541047]. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4
Elio Mazzone ... Francesco Montorsi
Annals of Oncology | VOL. -
Elio Mazzone, et. al.Elio Mazzone ... Francesco Montorsi
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
View more papers